Approval timelines could vary depending on results, regulatory review velocity, and new safety information
Apart from possible selenosis caused by excessive Se accumulation, intervention with micronutrient Se in subjects with adequate Se levels failed to reduce the incidence of thyroid cancer (82)
GLP-1 also slows down stomach emptying and increases the sense of fullness after eating
How These Pills Are Different From Current Injectables While oral and injectable GLP-1s share a similar active ingredient, their differences go beyond just the delivery method
Beta cell incretin receptor activity drives insulin secretion, an essential component of the antidiabetic response to either GLP-1R or GIPR agonists 10,18
[4] Even low doses can produce side effects: nausea, vomiting, slowed gastric emptying, occasional hypoglycemia, risk to people with certain GI issues